Dr Eddy Agbo

From Disrupting Africa
Jump to: navigation, search
Dr Eddy Agbo
Dr Eddy Agbo. Retrieved from Retrieved 4 March 2020.
Born1966 (age 56–57)
Mbu, Nigeria
Alma materWageningen University, University of Ibadan, Utrecht University
OccupationChairman/CEO and Founder of Fyodor Biotechnologies
Known forFounding Fyodor Biotechnologies
WebsiteLinkedIn Profile

Editor: Tamia Adolph

Dr Eddy Agbo is the founder and CEO of Fyodor Biotechnologies, a U.S. Maryland-based biotech company whose flagship product is the Urine Malaria Test (UMT). UMT is the first and only non-blood malaria test that diagnoses whether a fever is malaria or not, in 25 minutes or less. It is an inexpensive, at-home test similar to a pregnancy or blood sugar test that does not require medical health care professionals nor medical equipment.[1]


Dr Agbo is a Nigerian-born molecular biologist with a PhD in Molecular Genetics from Utrecht University, a Doctor of Veterinary Medicine from the University of Ibadan and a Master of Science in Biotechnology from Wageningen University.[2] He also obtained a Graduate Certificate in Leadership and Management in Life Sciences from John Hopkins University Business School.[3]

Agbo grew up in a small village named Mbu in Southeast Nigeria, where he witnessed the impact of diseases in his community.[4] He moved to the United States of America for his postdoctoral fellowship at John Hopkins University where he later worked as a senior researcher.[5] He later left John Hopkins to work for Cangen Biotechnologies as a senior director for research and preclinical development and a chief technical lead researcher.[6] Dr Agbo currently holds permanent US residency.[7]

As a postdoctoral fellow in infectious disease at John Hopkins University, Dr Agbo was inspired to create a testing service that is commercially viable and affordable.[8]

In 2008, Agbo founded Fyodor Biotechnologies and embarked on the development of their flagship product, the UMT. The UMT was inspired by Fyodor’s mission to create simple and easy use of biotechnologies that address global health issues.[9] From 2010 to 2011, Agbo was a member of Baltimore Mayor’s Business Roundtable in Maryland. From 2012 to 2015, he became a member of the Maryland Life Sciences Advisory Board that oversees a $1.3 billion fund established by the State of Maryland, USA to advance biotechnology in the State.

Achievements and Awards

Agbo was featured in the SmartCEO Magazine and Baltimore Business Journal in 2011.[10]

In 2014, he was the winner of the Outstanding Business Innovation Award by The Corporate Council on Africa in Washington DC, USA.

In 2015, Agbo was the star winner of the Nigeria Inaugural Health Innovation Challenge Award by the Private Sector Healthcare Alliance of Nigeria.

The UMT received the Special Prize for Social Impact at the Innovation Prize for Africa from the African Innovation Foundation in 2016.[11]

In 2017, Agbo was profiled in Harvard Business Review as one of Africa’s New Generation of Innovators.

In 2018, Agbo discussed industry diversification strategy in Africa at the African Development Bank Annual Meeting in Busan, South Korea.[12]

In the same year he was awarded the Innovation Prize from Universal Biotech in Paris, France.

In 2019, Agbo won the Swiss Re Foundation 2019 Resilience Award in Beijing, China.

Agbo was awarded the Outstanding Innovator of the Year from the US Corporate Council on Africa, as well as the “Innovation Award” from the Public Health Sector Alliance of Nigeria.[13]

Agbo has spoken at conferences and forums such as the Corporate Council on Africa, Africa Business Conference, and African Technology Policy Network.

Agbo is a member of the Greater Baltimore Committee USA which aims to better the business climate of the Greater Baltimore region. Furthermore, he is a member of its Bioscience Strategy Sub-committee.